Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors
Active, not recruiting · NCT02114229 · Registry updated 2026-09-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors | Neoplasms by Histologic Type, atypical teratoid rhabdoid tumor, mixed neoplasm, neoplasm, rhabdoid tumor | Active, not recruiting | Phase 2 | 2026-09-01 | NCT02114229 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Millennium Pharmaceuticals, Inc. | 9 |
| St. Jude Children's Research Hospital | 169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Healthcare of Atlanta | Atlanta | United States | 47 |
| Children's Hospital and Clinics of Minnesota | Minneapolis | United States | 2 |
| Children's Hospital Colorado | Aurora | United States | 312 |
| Children's National Medical Center | Washington D.C. | United States | 177 |
| Lucille Packard Children's Hospital at Stanford University Medical Center | Palo Alto | United States | 2 |
| Rady Children's Hospital | San Diego | United States | 52 |
| St. Jude Children's Research Hospital | Memphis | United States | 194 |
| Texas Children's Hospital | Houston | United States | 187 |
| UF Cancer Center at Orlando Health | Orlando | United States | 8 |